Catherine Isted has joined cell-based therapeutics company ReNeuron as chief financial officer.
Isted was previously head of corporate development and investor relations in the finance leadership team at Oxford Biomedica, and is a former partner in the healthcare equities team at Peel Hunt. She has also held research analyst and equity sales positions in the healthcare teams at Morgan Stanley, ABN AMRO and Nomura.
Iain Ross, ReNeuron chair, commented: “Catherine has an excellent knowledge of the healthcare sector and is highly skilled in equity capital markets, M&A and strategic business development. She will be a fantastic addition to the ReNeuron board and I am thoroughly looking forward to working alongside her.”
Related Posts
-
July 29, 2021
Mikells, a former CFO at Diageo, Xerox, ADT, Nalco and United Airlines, will take over from Andrew Swiger next month.
-
December 20, 2021
Moukheibir has extensive international experience in finance, capital markets and life sciences, including as CFO of Movetis.
-
July 19, 2021
Staehelin has led and co-founded four life science companies over a 30-year career in the international life sciences and technology sectors.
-
January 17, 2022
Williams is currently CFO and company secretary at French Connection Group, and will take up his new role in the first half of this year.